Canada markets closed

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.02+0.28 (+5.91%)
At close: 04:00PM EDT
5.01 -0.01 (-0.20%)
After hours: 04:14PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 703.75M
Enterprise Value 591.33M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.93
Price/Book (mrq)7.72
Enterprise Value/Revenue 10.12
Enterprise Value/EBITDA -8.90

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 3-17.57%
S&P500 52-Week Change 323.57%
52 Week High 311.31
52 Week Low 32.00
50-Day Moving Average 38.38
200-Day Moving Average 34.92

Share Statistics

Avg Vol (3 month) 32.58M
Avg Vol (10 day) 34.26M
Shares Outstanding 5148.63M
Implied Shares Outstanding 6154.73M
Float 8129.22M
% Held by Insiders 10.92%
% Held by Institutions 156.99%
Shares Short (Apr 15, 2024) 414.65M
Short Ratio (Apr 15, 2024) 48
Short % of Float (Apr 15, 2024) 410.31%
Short % of Shares Outstanding (Apr 15, 2024) 49.85%
Shares Short (prior month Mar 15, 2024) 49.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -138.15%
Operating Margin (ttm)-135.46%

Management Effectiveness

Return on Assets (ttm)-25.66%
Return on Equity (ttm)-127.64%

Income Statement

Revenue (ttm)58.44M
Revenue Per Share (ttm)0.73
Quarterly Revenue Growth (yoy)5.20%
Gross Profit (ttm)N/A
EBITDA -79.4M
Net Income Avi to Common (ttm)-80.74M
Diluted EPS (ttm)-1.02
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)195.81M
Total Cash Per Share (mrq)1.32
Total Debt (mrq)83.39M
Total Debt/Equity (mrq)91.50%
Current Ratio (mrq)6.66
Book Value Per Share (mrq)0.79

Cash Flow Statement

Operating Cash Flow (ttm)-70.23M
Levered Free Cash Flow (ttm)-49.44M